SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Papa John's International, Inc. engages in the operation and franchise of pizza delivery and carryout restaurants. It operates through the following segments: Domestic Company-owned Restaurants, North America Franchising, North America Commissaries, International Operations, and All Others. The Domestic Company-Owned Restaurants segment consists of retail sales of pizza and side items, breadsticks, cheese sticks, chicken poppers and wings, dessert items, and canned and bottled beverages. The North America Franchising segment involves the offering of sales and support activities, development rights, and collection of royalties from franchisees located in the United States and Canada. The North America Commissaries segment includes the eleven full-service regional dough production and distribution and quality control centers. The International Operations segment represents all restaurant operations outside of the United States and Canada. The All Others segment focuses on franchise contributions to marketing funds and sale, company-owned and franchised restaurants, information systems and related services used in restaurant operations, point-of-sale system, online and other technology-based ordering platforms, printing, and promotional items. The company was founded by John H. Schnatter in 1984 and is headquartered in Louisville, KY.

Papa John`s International, Inc.

Take-private speculation is the dominant topic, centered on Irth Capitals reported bid and a major U.S. franchisee joining the effort; traders are debating whether a deal will materialize, with no confirmed agreement in the discussion. The takeover hopes contrast with criticism of management and concern over weak sales, a dividend suspension, and the stocks steep decline.

Onyx is an infrastructure for a multi-asset, scalable, and cryptographically secure ledger. Onyx functions as a blockchain-based technology that enhances financial ecosystems by enabling a more efficient and interconnected economy, with a mission to develop cryptographic ledgers that optimize security, scalability, and usability. XCN is native to the Onyx XCN Ledger Blockchain as well as the Onyx Goliath Blockchain. XCN is also used as an ERC-20 token for Staking and Governance.

Onyxcoin

A sharp, news-unconfirmed XCN spike is driving attention, with traders reacting to a large candle and debating whether it marks a rebound or another brief pump-and-dump. Some are buying the dip and pointing to Bitcoins bounce, while skeptics say XCNs past spikes have quickly faded.

TOSHI

A burst of trading volume and a recent rebound have fueled talk of a technical breakout and a possible short squeeze in TOSHI, with many holders buying dips and anticipating a move through resistance. Others point to repeated failed breakouts, weak price action, and broader crypto-market softness; talk of an upcoming announcement or listing remains speculative.

ProShares Trust II - ProShares Ultra Bloomberg Crude Oil 2x Shares

ProShares Ultra Bloomberg Crude Oil

Crudes rally amid escalating Middle East tensions and fears of disrupted oil supplies is driving attention to UCO. Traders are divided between following the bullish momentum and positioning for a pullback, with some noting that geopolitical headlines could quickly shift the oil trade.

Amgen, Inc. is a biotechnology company, which engages in the discovery, development, manufacture, and marketing of human therapeutics. The company was founded by William K. Bowes, Jr., Franklin Pitcher Johnson, Jr., George B. Rathmann, and Joseph Rubinfeld on April 8, 1980 and is headquartered in Thousand Oaks, CA.

AMGEN Inc.

Amgens Phase 3 lung cancer results for IMDELLTRA plus AstraZenecas IMFINZI, which reduced the risk of death in first-line extensive-stage small cell lung cancer, are driving attention. Traders see the findings as a potential growth catalyst and debate how much they could expand the drugs commercial role alongside established products such as Repatha.

Select Sector SPDR Trust (The) - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

XLE is drawing attention after reaching a new high as energy stocks outperform, with traders pointing to rising crude prices and supply risks tied to Middle East tensions and shipping disruptions. The conversation is broadly bullish on the breakout, though some traders warn the rally may be extended and question whether it can hold.

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products. It operates through the following segments: Pharmaceutical, Animal Health, and Other. The Pharmaceutical segment includes human health pharmaceutical and vaccine products. The Animal Health segment discovers, develops, manufactures, and markets animal health products, such as pharmaceutical and vaccine products, for the prevention, treatment and control of disease in livestock, and companion animal species. The Other segment consists of sales for the non-reportable segments of healthcare services. The company was founded in 1891 and is headquartered in Rahway, NJ.

Merck & Co Inc

Mercks attention centers on Phase 3 results for its partnership with Moderna: the personalized cancer vaccine added to Keytruda reduced melanoma recurrence or death risk, drawing interest in the oncology platform and potential commercial upside. Traders debate whether the results justify further gains, given high expectations, unapproved status, and questions about manufacturing complexity and expansion beyond melanoma.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

Updated Phase 3 VIKTORIA-1 breast-cancer subgroup data presented at ESMO is drawing attention, with traders highlighting stronger progression-free survival and response results for gedatolisib combinations. Reactions are mixed: some see the findings as compelling, while others note the data builds on previously released topline results and say CELC still needs to demonstrate commercial uptake and revenue.

Shiba Inu (SHIB) is a decentralized, community-led cryptocurrency ecosystem built on the Ethereum blockchain. Originally launched as a meme-based project, it has evolved into a comprehensive financial ecosystem designed to offer a decentralized alternative to traditional banking. Its main value proposition lies in its transition from a social phenomenon into a functional utility network, supported by a vast global community known as the ShibArmy and a commitment to 100% community ownership with no central leadership.  The ecosystem features its own decentralized exchange, ShibaSwap, where users can trade, provide liquidity, and earn rewards. To address Ethereum’s high costs and slow speeds, the project utilizes Shibarium, a Layer 2 scaling solution that processes transactions faster and more affordably.  The project employs a unique three-token model to manage its economy and governance. SHIB serves as the primary currency for trading and payments, while LEASH offers scarcity-based incentives for dedicated supporters. BONE acts as the governance token, allowing holders to vote on proposals through the Doggy DAO and serving as the native gas token for the Shibarium network.

Shiba Inu

SHIB is drawing attention for choppy, largely sideways trading, with repeated technical posts describing consolidation and traders watching for a breakout. Holders are split between accumulating and anticipating a rebound, while skeptics point to weak momentum, limited utility, and the risk of further declines.

Anthropic

Anthropics anticipated blockbuster IPO is driving attention, with traders weighing rapid revenue growth against heavy compute commitments and reported losses. Some see a major AI-growth opportunity, while skeptics question whether the spending and intensifying competition can support the expected valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Can Tesla Bulls Strike Gold Twice? SpaceX IPO Puts The Elon Musk Premium To The Test 

Equity

Fidelity says SpaceX has reserved up to 30% of the IPO for retail investors, well above the typical 5%-10% allocation.

TSLA Stock Slips Overnight: SpaceX IPO Hype Is Starting To Look Like Amazon's Dot-Com Bubble Peak In 2000, Warns Ex-Lehman Trader 

McDonald said a $2 trillion valuation for SpaceX leaves little room for Tesla-like returns.

GraniteShares ETF Trust - GraniteShares 2x Short TSLA Daily ETF

Bearish Sentiment

<ul class="summary-bullets"><li>Tesla holders with over 10 years in TSLA are getting special access to SpaceX's historic IPO through Morgan Stanley's E*TRADE.</li><li>The IPO fulfills Musk's years-old pledge to prioritize retail investors and long-term Tesla shareholders.</li><li>'Dean of Valuation' Aswath Damodaran calls SpaceX a "loaded bet on AI and Elon Musk" but says momentum could still drive shares higher.</li></ul>Five years after Elon Musk promised to give long-term Tesla, Inc. (TSLA) shareholders priority access to a future space venture IPO, some investors are finally getting their chance. The question now is whether SpaceX can do for them what Tesla once did.After spending four of the year's first six months so far in the red,&nbsp;<a href="https://stocktwits.com/symbol/TSLA">TSLA shares</a> are staring down their worst year since 2022, despite a strong May rally that marked the stock's best month since September 2025.<h2 class="st-heading-2">Tesla Loyalists Get SpaceX Access</h2>E*TRADE has informed qualifying clients that it has established a supplemental allocation process for SpaceX's upcoming IPO, allowing investors who have held Tesla shares in their accounts for at least 10 years to receive additional consideration when seeking shares in the offering.The move comes as SpaceX prepares for what could be the largest IPO in history, raising a broader question that extends beyond the IPO process itself: are investors buying into a company, or are they once again betting on Elon Musk?SpaceX plans to sell 555.6 million shares at $135 each, raising $75 billion and valuing the company at a massive $1.77 trillion. The valuation could also exceed $1.8 trillion on a fully diluted basis. The offering is scheduled to price on June 11, with shares expected to begin trading the next day.Investor demand has&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/transactional/spacex-tells-banks-it-wont-move-its-135-a-share-ipo-price-2026-06-04/">reportedly</a> been exceptionally strong after a JPMorgan-hosted roadshow, where Musk outlined plans to expand Starlink to more than 100,000 satellites and build orbital AI infrastructure. Analysts involved in the roadshow have apparently been fielding 20 investor calls per day, above the 10 to 15 calls typically seen for highly sought-after IPOs.The filing itself painted an enormous vision for the company, outlining a $28.5 trillion market opportunity spanning launch services, Starlink connectivity, direct-to-cell communications and AI infrastructure. SpaceX called it the "largest actionable total addressable market in human history."The filing added fuel to one of Wall Street's favorite Musk theories. SpaceX disclosed it may issue a significant amount of equity in future transactions, reviving chatter about potential stock-based deals and even a future merger of Musk's two most valuable companies.&nbsp;<h2 class="st-heading-2">Musk's Retail Promise Comes Full Circle</h2>The special allocation program traces back to comments Musk made in 2021 when discussing a potential SpaceX public offering: "At least a few years before Starlink revenue is reasonably predictable. Going public sooner than that would be very painful. Will do my best to give long-term Tesla shareholders preference," Musk&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/1407877220543180800">said on X</a> at the time. In another post from 2020, Musk favored retail investors by&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/1310672832783884290">saying</a>: "I'm a huge fan of small retail investors. Will make sure they get top priority [when SpaceX goes public]. You can hold me to it."Alongside E*TRADE's special allocation process, Fidelity said the company has reserved up to 30% of the IPO for retail investors, far above the 5%-10% typically allocated in most high-profile listings. The larger retail allocation prompted Fidelity to lower eligibility requirements for participation to customers with as little as $2,000 in a brokerage account.While SpaceX ultimately chose to take the parent company public rather than spin off Starlink, many retail investors view the allocation programs as a fulfillment of Musk's years-old pledge to give individual investors and loyal Tesla shareholders a seat at the IPO table.<h2 class="st-heading-2">The Elon Musk Premium</h2>NYU professor Aswath Damodaran, deemed as the "Dean of Valuation," estimated SpaceX's equity value at $1.25 trillion to $1.35 trillion, below the IPO valuation. He said the company is "too richly priced" for his investment style at current levels. Still, Damodaran acknowledged that traders focused on momentum rather than intrinsic value may see things differently: "I would not be surprised in the least to see the offering priced at $1.8 trillion, and see a jump in the price on the day of or in the weeks after the offering," he wrote.His broader conclusion was that SpaceX is ultimately a wager on Musk and AI: "There is no denying that this company is a loaded bet on the AI and Elon Musk," Damodaran said, adding that some investors may look at "Musk's track record with Tesla and feel the odds are in their favor."<h2 class="st-heading-2">A Backdoor Into The S&amp;P 500?</h2>The IPO frenzy comes despite a setback this week from S&amp;P Dow Jones Indices. The index provider said it would make "no changes" to eligibility requirements for the S&amp;P 500, S&amp;P MidCap 400 and S&amp;P SmallCap 600 after a consultation on newly listed megacap companies. The decision is significant since SpaceX reported a $4.94 billion net loss in 2025. Under existing rules, S&amp;P 500 constituents must generate positive GAAP earnings in both the latest quarter and the trailing four quarters.However, Tesla influencer Alexandra Merz, who posts on X under the handle TeslaBoomerMama,&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/TeslaBoomerMama/status/2062706301013299472">argued</a> that S&amp;P's decision may ultimately leave the timing of SpaceX's index inclusion in Musk's hands.&nbsp;"S&amp;P will regret this," Merz&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/TeslaBoomerMama/status/2062665755808968705">said on X</a>. "Now it's Elon deciding when SpaceX gets included, by merging with Tesla."Merz said that S&amp;P's decision leaves open an alternative route for SpaceX. Since Tesla is already an S&amp;P 500 constituent, she said a future stock-for-stock merger between the two companies could allow the combined entity to inherit Tesla's place in the index, potentially accelerating SpaceX's path to inclusion. Notably, no such transaction has been proposed by either company.&nbsp;<h2 class="st-heading-2">How Do Retail Traders Feel About TSLA And SpaceX?</h2>On Stocktwits, retail sentiment for TSLA over the past six months has mostly been bearish amid over a 60% decline in message volumes in a year. Retail investors who have pinned TSLA on their watchlist have risen by a modest 2% over the past year.&nbsp;<figure class="image"><img src="https://news.stocktwits-cdn.com/tsla_ss_png_d95ab06a53.webp" alt="tsla ss.png" width="974" height="131"><figcaption>TSLA sentiment and message volume as of June 5 | Source: Stocktwits</figcaption></figure>One user&nbsp;<a href="https://stocktwits.com/Jimmyjj200/message/655499505">speculated</a> anxiously, “will $TSLA pop tomorrow? Will enough retail investors have FOMO before SPACEX ipo thinking<a href="https://stocktwits.com/symbol/TSLA"> $TSLA</a> will run and get it this week ?? I don’t know just a feeling…..”<stembedurl>https://stocktwits.com/Jimmyjj200/message/655499505</stembedurl>Another user&nbsp;<a href="https://stocktwits.com/MichaelOb/message/655499568">said</a>, “$TSLA trades to nearly 400 trailing P/E and 200 forward P/E, TSLA is a cult stock so likely SpaceXAI will be too, it will 100% go up on the first day so if you buy in at the start and dump before the day is over you can net a tidy profit”<stembedurl>https://stocktwits.com/MichaelOb/message/655499568</stembedurl>So far this year, TSLA stock has lagged its “Magnificent Seven” peers, making it the group’s second-worst performer, with a 7% decline.&nbsp;&nbsp;&nbsp;&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/rivn-stock-snaps-record-streak-ahead-of-r2-launch/cZ0FIXlRezn">RIVN Stock Snaps Record Streak: Rivian Reverses R1 Discounts Days Before High-Stakes R2 Launch&nbsp;</a>

Tech billionaire and Tesla founder Elon Musk at a meeting. US President Trump is accompanied by a large business delegation on his visit to China. Photo: Johannes Neudecker/dpa (Photo by Johannes Neudecker/picture alliance via Getty Images)

Morgan Stanley

SpaceX

GraniteShares 2x Short TSLA Daily ETF

GraniteShares 1.25x Long Tesla Daily ETF

Direxion Daily TSLA Bull 2X Shares

Up more than 1%

Flat to up 1%

Flat to down 1%

Down more than 1%

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Feed

News

Sentiment

Fundamentals

Info

TSDD GraniteShares 2x Short TSLA Daily ETF

Fundamentals

Latest TSDD News